![]() ![]() The epidemiology of meconium aspiration syndrome: incidence, risk factors, therapies and outcome. Pathophysiology of meconium passage into the amniotic fluid. A fulltenn neonate 'With respiratory distress and meconium staining. Risk factors for meconium aspiration in meconium stained amniotic fluid. Khazardoost S, Hantoushzadeh S, Khooshideh M, oorna S. The effect of meconium on perinatal outcome: a prospective analysis. Sheiner E, Hadar E, Vaidi SI, Hallak M, Katz M, Mazor M. Incidence of and factors associated with meconium staining of the amniotic fluid in a Nigerian Univercity Teaching HospitaL J Obstet GynaecoL 2006 26:518-20.ġ6. An 8ô€ year study of meconium stained amniotic fluid in different ethnic groups. Sedaghatian MR, Othman L, Rashid N, Ramachandran P, Bener AB. ![]() Neonatal outcome after caesarean birth for fetal distress and/or meconium staining in South Africa rural setting. ![]() Predictor of meconium stained amniotic fluid: a possible strategy to reduce neonatal morbidity and mortality. Khatun HA, Arzu J, Haque E, Kamal MA, Almamun MA, Khan MFH, et aL Fetal outcome in deliveries 'With meconium stained liquor. Neonatal outcome in meconium stained amniotic fluidô€ one year experience. Semarang: Clinical Pathology, Medical School, Diponegoro University 2003.ġ0. Meconium aspiration syndrome: Intrapartum and neonatal attributes. Rossi EM, Philipson EH, W illiams TG, Kalhan SC. The association between meconiumô€ stained amniotic fluid and chorioamnionitis or endometritis. Panichkul S, Boonpraset K, Komolpis S, Panickul P, Caengow S. Meconium aspiration syndrome: pathophysiology and prevention. Intrapartum and postdelivery management of infants born to mothers 'With meconium-stained amniotic fluid: Evidenceô€ based recommendations. Evaluation and management of neonates 'With meconium stained amniotic fluid. Narli N, Kirim i E, Satar M, Turkmen M, Halaza M, Yapicioglu H. Perspective on meconium staining of the amniotic fluid. New York: Lange medical Book/ Mc.Graw Hill Co 2004. Neonatology management, procedures, onô€ call problems, diseases and drugs. Hyaline membrane disease (respiratory distress syndrome). Departemen Kesehatan RI,IDAI,MNH,) HPIEGO,MPK, KR.Jakarta: Departemen Kesehatan RI 2007. Pelatihan PONED komponen neonataL Maternal Neonatal Health. Kosim MS, Indarso F, Irawan G, Hendarto W. Stercobilin and bilirubin presence in MSAF were not associated with MAS.ġ. 6), while stercobilin and bilirubin presence did not.Ĭonclusion Thick MSAF was associated Mth lvtAS and was a risk factor for MAS. Thick MSAF correlated significantly to MAS (P=0.03) Mth a relative risk of 10.1 (95% CI 1.2 to 87. The MSAF tested ositively for stercobilin and bilirubin in 12/48 and 17/48 subjects, respectively. Classification of MSAF as thick or thin was done by macroscopic examination Mth Kappa test 0.741. Results The majority of the 48 subjects were male, Mth mean gestational age of 39.9 (SD 1.73) weeks. Analysis was done by chi-square test, Fisher's exact test and relative risk. Amniotic fluid specimens were taken at birth and neonates were observed for respiratory symptoms until the 5th day of life. Methods This observational cohort study was perfonned with term babies who were born v.ith MSAF in Kariadi Hospital from August 2009 to May 2010. Objective To determine the associations between viscosity and the presence of stercobilin and bilirubin in MSAF with MAS in neonates. Viscosity of MSAF is associated with the amount of the meconium release. Meconium aspiration syndrome (MAS) occurs in 2-9% of neonates with MSAF. Background Meconium-stained amniotic fluid (MSAF) increases morbidity and mortality in neonates. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |